A tau-related blood test could offer more insight in early-disease pathology to the complicated Alzheimer’s disease space.
In this interview, Felix Spira, senior manager at Molecular Devices, discusses how automation and AI improve brain organoid ...
Objective Inflammation and repair responses may be involved in atherosclerosis in rheumatoid arthritis (RA), although ...
Objective Serum amyloid A (SAA) is a protein involved in the acute phase of inflammation. SAA expression is upregulated in humans during the acute phase of various viral infections; in addition, SAA ...
Advanced Provides Clarity in 3D Heartflow Plaque Analysis is the only FDA-cleared, AI-powered plaque quantification tool with a reported 95% agreement with the gold standard, IVUS, using blinded core ...
Researchers from University of California San Diego School of Medicine have found that testing for lipoprotein(a)—a genetic ...
Medical Device Network on MSN
Heartflow secures FDA clearance for updated plaque analysis platform
The updated plaque analysis technology is said to enhance coronary artery disease diagnosis with an improved algorithm.
CENTENNIAL, CO / ACCESS Newswire / September 17, 2025 / NioCorp Developments Ltd. (“NioCorp” or the “Company“) (NASDAQ:NB) today announced the pricing of a registered direct offering in the United ...
The company just completed its Neutron launch pad, signaling progress toward a full launch for its heavy-lift rocket. Rocket Lab's $22 billion valuation appears stretched against its $500 million in ...
Discover Alector's latest breakthroughs in neurodegenerative disease therapies, including updates on Alzheimer's and Parkinson's programs.
News-Medical.Net on MSN
Blood and brain biomarkers transform how doctors confirm Alzheimer’s disease
A new Lancet review proposes a three-wave diagnostic pathway that combines clinical expertise with blood, CSF, and PET ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results